BJH - 2021, issue SPECIAL, january 2021
dr. J. Van Dorpe
Cell-free plasma DNA (cfDNA) and circulating tumour DNA (ctDNA) represent potential alternative sources of diagnostic information. During his lecture at the 2021 BHS general annual meeting Dr. Jo Van Dorpe discussed the potential of these liquid biopsies in the diagnostic work-up of different lymohoma subtypes.
Read moreBJH - volume 11, issue Abstract Book BHS, february 2020
E. Linskens , S. Van Landeghem , K. Vandepoele PhD, dr. K. Maes , I. Moors MD, dr. J. Van Dorpe , C. Bonroy , K. Devreese , J. Philippé MD, PhD, B. Denys MD
BJH - volume 11, issue Abstract Book BHS, february 2020
K. Voet , dr. J. Van Dorpe , P. Vlummens MD, D. Mazure MD
BJH - volume 11, issue Abstract Book BHS, february 2020
E. Janssens , dr. J. Van Dorpe , V. Van Hende MD, I. Moors MD, P. Vlummens MD, C. De Vriendt
BJH - volume 9, issue 6, november 2018
K. Imaeva , I. Moors MD, dr. J. Van Dorpe , S. Verbeke , B. Denys MD
Blastic plasmacytoid dendritic cell neoplasm is a highly aggressive myeloid neoplasm with a high rate of central nervous system recurrence. We present a case to illustrate central nervous system involvement and possible treatment options.
(BELG J HEMATOL 2018;9(6):237–41)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
B. Denys MD, J. Van der Meulen , E. de Latter , S. Lefever , T. Rosseel , W. Steyaert , G. Vandercruyssen , I. Rottiers , D. Creytens , dr. J. Van Dorpe , F. Speleman PhD, B. Poppe , N. Van Roy PhD, K. de Leeneer , K. Claes BM, PhD, K. Vandepoele PhD
Top
